Skip to main content
Enterprise AI Analysis: Accelerating Disease Model Parameter Extraction: An LLM-Based Ranking Approach to Select Initial Studies For Literature Review Automation

Enterprise AI Analysis

Accelerating Disease Model Parameter Extraction: An LLM-Based Ranking Approach to Select Initial Studies For Literature Review Automation

This study demonstrates that a zero-shot LLM-based QA assessor, using fine-grained labels, can effectively and reliably rank primary studies by relevance across four climate-sensitive zoonotic disease datasets with varying relevance rates. It achieves significant work savings (at least 70% at 95% recall) compared to manual screening. The approach also generates explainable AI rationales, which aid human reviewers in identifying misclassifications and enhance transparency.

Executive Impact Summary

Our analysis reveals several key advancements in automating systematic literature reviews using Large Language Models.

0% Work Effort Saved
0% Recall Rate
0 Disease Models

Deep Analysis & Enterprise Applications

Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.

The research explores the application of generative Large Language Models (LLMs) as assessors for screening prioritisation in systematic literature reviews (SLRs). It highlights LLMs' capacity for advanced natural language understanding and zero-shot task solving, contrasting with traditional methods that require extensive fine-tuning. The QA framework approach enhances transparency and interpretability by capturing model reasoning.

The study focuses on climate-sensitive zoonotic diseases, an area where SLRs are challenging due to multidisciplinary research spanning epidemiology, ecology, and public health. Accurate parametrization of disease models is critical for forecasting outbreaks, and this research aims to accelerate data extraction from diverse scientific literature.

A key contribution is the generation of Chain-of-Thought (CoT) rationales for each ranked article. This allows human reviewers to understand the LLM's decision-making process, detect misclassifications, and iteratively refine the ranking process. This enhances trust and transparency, addressing a common limitation of 'black-box' AI systems.

0.691 Highest MAP Score Achieved (QA-4), indicating superior ranking quality and resilience to imbalanced datasets.

Enterprise Process Flow

Establish SLR Protocol & Selection Criteria
Develop QA Framework & Prompts
LLM Processes Title/Abstracts (Zero-Shot CoT)
LLM Assessor Ranks Documents (Scores & Rationales)
Human Reviewer Verifies & Refines

LLM QA Assessors vs. Baseline Models (Key Advantages)

Feature LLM QA Assessors (e.g., QA-4) Baseline Models (e.g., TSC-BM25)
Work Effort Saved (nWSS@95%)
  • Up to 86% (Ebola)
  • As low as 2% (Ebola)
Ranking Quality (MAP)
  • 0.691 (highest)
  • 0.229 (lowest)
Explainability
  • Provides CoT rationales
  • Limited to none
Generalisability
  • Strong across diverse diseases & relevancy rates
  • Variability in performance

Impact on Ebola Research (Highly Skewed Dataset)

In the Ebola dataset, which had a particularly pronounced skew with only 1.5% relevant records, QA-4 and QA-5 models demonstrated significantly high recall, achieving complete recall at k = 15%. This highlights the robustness of the LLM-based QA approach even with highly imbalanced datasets, where traditional methods often struggle.

Calculate Your Potential ROI

Estimate the time and cost savings your organization could achieve by automating literature reviews with our AI solution.

Estimated Annual Savings $0
Hours Reclaimed Annually 0

Your AI Implementation Roadmap

A structured approach to integrating our advanced AI solutions into your existing workflows.

Phase 01: Discovery & Strategy

Initial consultations to understand your specific needs, data landscape, and define clear objectives for AI integration. We'll outline a tailored strategy.

Phase 02: Pilot & Validation

Implement a proof-of-concept on a subset of your data. This phase focuses on validating the AI's performance, fine-tuning models, and demonstrating initial ROI.

Phase 03: Full-Scale Integration

Seamlessly integrate the validated AI solution into your enterprise systems, providing training for your team and continuous support to ensure smooth operation.

Phase 04: Optimization & Expansion

Ongoing monitoring, performance optimization, and exploration of additional use cases to maximize long-term value and adapt to evolving business needs.

Ready to Transform Your Research?

Book a free consultation with our AI specialists to discuss how our solutions can empower your team and accelerate your scientific discovery.

Ready to Get Started?

Book Your Free Consultation.

Let's Discuss Your AI Strategy!

Lets Discuss Your Needs


AI Consultation Booking